LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Esperion (NASDAQ: ESPR)

Follow NASDAQ:ESPR Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ESPR Esperion
Hoffman Robert E. / director
04/01/2025
Buy
$1.41
40,000
$56K
40,000
NASDAQ ESPR Esperion
Halladay Benjamin / officer: Chief Financial Officer
03/18/2025
Sell
$1.48
3,535
$5K
481,710
NASDAQ ESPR Esperion
Warren Eric / officer: Chief Commercial Officer
03/18/2025
Sell
$1.49
2,433
$4K
370,326
NASDAQ ESPR Esperion
Koenig Sheldon L. / director, officer: President and CEO
03/18/2025
Sell
$1.50
13,047
$20K
1.57M
NASDAQ ESPR Esperion
Koenig Sheldon L. / director, officer: President and CEO
03/14/2025
Buy
$1.50
753,000
$1.130M
753,000
NASDAQ ESPR Esperion
Halladay Benjamin / officer: Chief Financial Officer
03/14/2025
Buy
$1.50
213,000
$320K
213,000
NASDAQ ESPR Esperion
Warren Eric / officer: Chief Commercial Officer
03/14/2025
Buy
$1.50
191,000
$287K
191,000
NASDAQ ESPR Esperion
Looker Benjamin / officer: General Counsel
03/14/2025
Buy
$1.50
201,000
$302K
201,000
NASDAQ ESPR Esperion
Warren Eric / officer: Chief Commercial Officer
02/19/2025
Sell
$1.87
239
$446
159,759
NASDAQ ESPR Esperion
Halladay Benjamin / officer: Chief Financial Officer
02/19/2025
Sell
$1.86
11
$20
240,671

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous